{
  "url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-3",
  "json_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-3.json",
  "legislation": "uksi/2010/1614",
  "legislation_title": "The General Pharmaceutical Council (Appeals Committee Rules) Order of Council 2010",
  "legislation_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010",
  "path": "schedule/paragraph/3",
  "kind": "paragraph",
  "number": "3",
  "heading": "Service of documents",
  "text": "(1) For the purposes of these Rules any notice or document required to be served by the secretary must be in writing and must, subject to paragraphs (2) and (3), be served by sending it by a postal service or another delivery service to, or by leaving it at—\n(a) in the case of an individual who is a registrant, the registrant’s home address in the Register;\n(b) in the case of an individual who is not a registrant, the individual’s last known home address;\n(c) in the case of a partnership, the principal office of that partnership;\n(d) in the case of a body corporate, the registered or principal address of that body corporate; and\n(e) in the case of an institution or other provider which is appealing against a decision under article 47(6)(a) or (b) of the Order, the last known address of that institution or other provider.\n(2) Notices or documents may be sent to a person under these Rules by electronic mail to an electronic mail address notified by that person to the Council as an address for communications.\n(3) If a person to whom a notice or document is to be sent under these Rules so agrees, notices or documents may be sent to or left at—\n(a) where the person is represented by a solicitor, the solicitor’s practising or electronic mail address; or\n(b) where the person is represented by a defence organisation or trade union, the business or electronic mail address of that defence organisation or trade union.\n(4) In paragraphs (2) and (3), references to “person” include references to a person representing an institution or other provider referred to in paragraph (1)(e).\n(5) Where any notice or document is sent by the secretary by a postal service, unless sent by a service which records the date of delivery, it must be sent by first class post and is to be treated as having been served on the day after the day on which it was posted.\n(6) Where any notice or document is sent by electronic mail or left at an address, it is to be treated as having been served on the day at which it was sent to or left at that address.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Sch. rule 3(2) substituted (4.3.2021) by The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021 (S.I. 2021/26), art. 1, Sch. rule 2(4)(a)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Word in Sch. rule 3(2) substituted (4.3.2021) by The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021 (S.I. 2021/26), art. 1, Sch. rule 2(4)(b)"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. rule 3 in force at 27.9.2010, see rule 1"
    }
  ],
  "outstanding_effects": [
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2010/1614/schedule/paragraph/3",
    "retrieved_at": "2026-10-29T02:38:45.129905+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}